Agilon Health Inc (AGL) concluded trading on Thursday at a closing price of $2.55, with 4.72 million shares of worth about $12.03 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 18.06% during that period and on May 15, 2025 the price saw a loss of about -4.49%. Currently the company’s common shares owned by public are about 413.02M shares, out of which, 296.92M shares are available for trading.
Stock saw a price change of -20.81% in past 5 days and over the past one month there was a price change of -53.89%. Year-to-date (YTD), AGL shares are showing a performance of 34.21% which decreased to -51.06% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $1.50 but also hit the highest price of $7.73 during that period. The average intraday trading volume for Agilon Health Inc shares is 6.30 million. The stock is currently trading -29.93% below its 20-day simple moving average (SMA20), while that difference is down -38.27% for SMA50 and it goes to -26.67% lower than SMA200.
Agilon Health Inc (NYSE: AGL) currently have 413.02M outstanding shares and institutions hold larger chunk of about 73.52% of that.
The stock has a current market capitalization of $1.06B and its 3Y-monthly beta is at 0.21. It has posted earnings per share of -$0.62 in the same period. It has Quick Ratio of 1.20 while making debt-to-equity ratio of 0.08. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for AGL, volatility over the week remained 9.49% while standing at 11.95% over the month.
Stock’s fiscal year EPS is expected to rise by 46.31% while it is estimated to increase by 33.10% in next year. EPS is likely to grow at an annualized rate of 41.11% for next 5-years, compared to annual growth of 3.29% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Citigroup on April 25, 2025 offering a Buy rating for the stock and assigned a target price of $5 to it. Coverage by Bernstein stated Agilon Health Inc (AGL) stock as an Outperform in their note to investors on April 08, 2025, suggesting a price target of $8.50 for the stock. Stock get a Neutral rating from Macquarie on December 16, 2024.
